TITLE

Spinal intrathecal baclofen suppresses central pain after a stroke

AUTHOR(S)
Taira, T; Tanikawa, T; Kawamura, H; Iseki, H; Takakura, K
PUB. DATE
March 1994
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Mar1994, Vol. 57 Issue 3, p381
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66107011

 

Related Articles

  • Manejo del síndrome de abstinencia por interrupción del baclofeno. Santana, Lisgelia; Quintero, Manuel // Colombian Journal of Anesthesiology / Revista Colombiana de Anes;May-Jul2012, Vol. 40 Issue 2, p158 

    Intrathecal baclofen therapy is a treatment that can relieve some symptoms of severe spasticity. Currently intrathecal baclofen infusion is used primarily for spasticity associated with cerebral palsy, brain or spinal injury, traumatic brain injury, anoxic encephalopathy, multiple sclerosis,...

  • An intrathecal option. Carroll Ward, Lorrie A. // RN;Jan2001, Vol. 64 Issue 1, p39 

    Discusses the use of intrathecal baclofen for the management of painful muscle rigidity and severe spasms in patients with brain and spinal injury. Details on intrathecal administration; Patient selection; Screening trial.

  • Deep Venous Thrombosis Associated With Use of Intrathecal Baclofen Pump in Chronic Spinal Cord Injury: A Report of Two Cases. SAFAZ, İsmail; KESIKBURUN, Serdar; TUĞCU, İlknur; ALACA, Rıdvan; TAN, Arif Kenan // Journal of Neurological Sciences;2014, Vol. 31 Issue 4, p842 

    By providing a direct and selective effect at the spinal cord level, intrathecal baclofen is used for the treatment of spasticity of spinal or cerebral origin, which is not alleviated with oral antispastic drugs. Besides its potent effect, it may result in several adverse events. The most common...

  • Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial. Bonouvrié, Laura A; Becher, Jules G; SH Vles, Johannes; Boeschoten, Karin; Soudant, Dan; de Groot, Vincent; van Ouwerkerk, Willem JR; LM Strijers, Rob; Foncke, Elisabeth; Geytenbeek, Joke; van de Ven, Peter M; Teernstra, Onno; Vermeulen, R Jeroen // BMC Pediatrics;2013, Vol. 13 Issue 1, p1 

    Background Dystonic cerebral palsy is primarily caused by damage to the basal ganglia and central cortex. The daily care of these patients can be difficult due to dystonic movements. Intrathecal baclofen treatment is a potential treatment option for dystonia and has become common practice....

  • The Course of Intrathecal Baclofen Treatment for a Patient with Cervical Spinal Cord Injury. YOSHIMURA, SUSUMU; YOSHIMOTO, YOSHINOBU; KATATA, YUJI; HAMAOKA, KATSUMI; OYAMA, YUKITSUNA; KAJITANI, MITSURU // Rigakuryoho Kagaku;2010, Vol. 25 Issue 4, p641 

    [Purpose] We report the case of a patient with cervical spinal cord injury who received intrathecal baclofen as physical therapy. [Results] The patient's Ashworth scale (mean) spasticity score was 3.0, and the transfer activity between bed and wheelchair was five points on the Functional...

  • Intrathecal AAV Serotype 9-mediated Delivery of shRNA Against TRPV1 Attenuates Thermal Hyperalgesia in a Mouse Model of Peripheral Nerve Injury. Hirai, Takashi; Enomoto, Mitsuhiro; Kaburagi, Hidetoshi; Sotome, Shinichi; Yoshida-Tanaka, Kie; Ukegawa, Madoka; Kuwahara, Hiroya; Yamamoto, Mariko; Tajiri, Mio; Miyata, Haruka; Hirai, Yukihiko; Tominaga, Makoto; Shinomiya, Kenichi; Mizusawa, Hidehiro; Okawa, Atsushi; Yokota, Takanori // Molecular Therapy;Feb2014, Vol. 22 Issue 2, p409 

    Gene therapy for neuropathic pain requires efficient gene delivery to both central and peripheral nervous systems. We previously showed that an adenoassociated virus serotype 9 (AAV9) vector expressing short-hairpin RNA (shRNA) could suppress target molecule expression in the dorsal root ganglia...

  • Intrathecal baclofen: Its effect on symptoms and activities of daily living in severe spasticity due to spinal cord injuries: A pilot study. Jagatsinh, Yogendrasinh // Indian Journal of Orthopaedics;Jan-Mar2009, Vol. 43 Issue 1, p46 

    Background: Spasticity is a major problem related to spinal cord injuries. Use of intrathecal baclofen with an implanted pump seems a very useful mode of therapy in patients in whom oral antispasmodic agents are either not effective or produce intolerable side-effects. Materials and Methods:...

  • Baclofen overdose.  // Reactions Weekly;6/26/2004, Issue 1007, p8 

    Presents a case study of boy who has developed baclofen toxicity including central nervous system and cardiovascular disorders during treatment with an intrathecal baclofen pump. Findings of the medical examination of the boy; Improvements observed on the boy after receiving physostigmine.

  • Baclofen overdose/withdrawal.  // Reactions Weekly;2/25/2006, Issue 1090, p6 

    Presents a case report on central nervous system and cardiovascular disorders with respiratory insufficiency followed by withdrawal of baclofen, a gamma-aminobutyric acid, in a child. Development of the disease after the withdrawal of intrathecal baclofen; Use of the drug to treat cerebral...

  • Spasticity: pathophysiology, evaluation and management. Kheder, Ammar; Padmakumari Sivaraman Nair, Krishnan // Practical Neurology (BMJ Publishing Group);Oct2012, Vol. 12 Issue 5, p289 

    Spasticity is common in many neurological disorders, such as stroke and multiple sclerosis. It is part of the upper motor neurone syndrome manifesting as increased tone, clonus, spasms, spastic dystonia and co-contractions. The impact of spasticity varies from it being a subtle neurological sign...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics